Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis

Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis

Emmanuel Kwateng Drokow,1 Hafiz Abdul Waqas Ahmed,1 Cecilia Amponsem-Boateng,2 Gloria Selorm Akpabla,3 Juanjuan Song,1 Mingyue Shi,1 Kai Sun11Department of Hematology, Zhengzhou University People‘s Hospital & Henan Provincial People‘s Hospital Henan, Zhengzhou, People&...

Full description

Bibliographic Details
Main Authors: Drokow EK, Ahmed HAW, Amponsem-Boateng C, Akpabla GS, Song J, Shi M, Sun K
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Autologous
CD19
CAR-T
haematological malignancies
Response rate
Online Access:https://www.dovepress.com/survival-outcomes-and-efficacy-of-autologous-cd19-chimeric-antigen-rec-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/survival-outcomes-and-efficacy-of-autologous-cd19-chimeric-antigen-rec-peer-reviewed-article-TCRM

Similar Items